Processa Pharmaceuticals Valuation
| PCSA Stock | USD 3.23 0.30 10.24% |
At this time, the company appears to be undervalued. Processa Pharmaceuticals holds a recent Real Value of $8.75 per share. The prevailing price of the company is $3.23. Our model determines the value of Processa Pharmaceuticals from analyzing the company fundamentals such as Shares Outstanding of 2.27 M, shares owned by institutions of 7.81 %, and Return On Equity of -2.71 as well as examining its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that Processa Pharmaceuticals' price fluctuation is very risky at this time. Calculation of the real value of Processa Pharmaceuticals is based on 3 months time horizon. Increasing Processa Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Processa Pharmaceuticals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Processa Stock. However, Processa Pharmaceuticals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 3.23 | Real 8.75 | Hype 3.4 | Naive 2.73 |
The real value of Processa Stock, also known as its intrinsic value, is the underlying worth of Processa Pharmaceuticals Company, which is reflected in its stock price. It is based on Processa Pharmaceuticals' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Processa Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Processa Pharmaceuticals helps investors to forecast how Processa stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Processa Pharmaceuticals more accurately as focusing exclusively on Processa Pharmaceuticals' fundamentals will not take into account other important factors: Processa Pharmaceuticals Total Value Analysis
Processa Pharmaceuticals is at this time projected to have valuation of 330.28 K with market capitalization of 7.32 M, debt of 73.51 K, and cash on hands of 12.06 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Processa Pharmaceuticals fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
330.28 K | 7.32 M | 73.51 K | 12.06 M |
Processa Pharmaceuticals Asset Utilization
One of the ways to look at asset utilization of Processa is to check how much profit was generated for every dollar of assets it reports. Processa Pharmaceuticals holds a negative application of assets of -1.3 pct., losing $0.013 for each dollar of assets held by the company. Inadequate asset utilization implies the company is being less effective with each dollar of assets it holds. Put it differently, asset utilization of Processa Pharmaceuticals shows how discouraging it operates for each dollar spent on its assets.Processa Pharmaceuticals Ownership Allocation
Processa Pharmaceuticals holds 10.73 pct. of its outstanding shares held by insiders and 7.81 pct. owned by third-party entities.Processa Pharmaceuticals Profitability Analysis
Net Loss for the year was (11.85 M) with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Processa Pharmaceuticals' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Processa Pharmaceuticals and how it compares across the competition.
About Processa Pharmaceuticals Valuation
The stock valuation mechanism determines Processa Pharmaceuticals' current worth on a weekly basis. Our valuation model uses a comparative analysis of Processa Pharmaceuticals. We calculate exposure to Processa Pharmaceuticals's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Processa Pharmaceuticals's related companies.Processa Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development of drug products for the treatment of patients with unmet medical needs in the United States. The company was incorporated in 2011 and is based in Hanover, Maryland. Processa Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 15 people.
Complementary Tools for Processa Stock analysis
When running Processa Pharmaceuticals' price analysis, check to measure Processa Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Processa Pharmaceuticals is operating at the current time. Most of Processa Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Processa Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Processa Pharmaceuticals' price. Additionally, you may evaluate how the addition of Processa Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |